期刊文献+

新生儿呼吸窘迫综合征合并呼吸机相关性肺炎患儿死亡相关因素Logistic回归分析 被引量:8

Logistic Regression Analysis of Related Factors of Death in Neonates with Respiratory Distress Syndrome and Ventilator-associated Pneumonia
下载PDF
导出
摘要 目的分析新生儿呼吸窘迫综合征(NRDS)合并呼吸机相关性肺炎(VAP)患儿死亡的相关因素并提出相应防控措施。方法回顾性分析2013年2月-2019年9月277例NRDS合并VAP患儿的临床资料,收集并记录相关临床资料,计算死亡率并对相关因素进行单因素与多因素分析。结果NRDS合并VAP患儿死亡率22.02%;出生胎龄<28周、羊水污染、胎膜早破、入院时日龄<7 h、出生体质量<1000 g、APACHEⅡ评分>15分、机械通气时间>7 d、感染类型(迟发型)、并发症、多重耐药菌感染、PCT>0.5μg/L共11个因素是NRDS合并VAP患儿死亡的危险因素(P<0.05);肺表面活性物质是NRDS合并VAP患儿死亡的保护因素(P<0.05)。多因素分析显示出生体质量<1000 g、出生胎龄<28周、机械通气时间>7 d、多重耐药菌感染、降钙素原(PCT)>0.5μg/L共5个因素是NRDS患儿VAP死亡的独立危险因素(P<0.05)。结论NRDS合并VAP患儿死亡率较高,加强超早产-极低体质量儿的管理,做好多重耐药菌感染的防控,早期拔管减少不必要的机械通气时间是减少NRDS合并VAP患儿死亡的主要措施;血清PCT监测可预测NRDS合并VAP患儿治疗效果并为临床干预提供依据。 Objective To analyze the related factors of death in neonates with respiratory distress syndrome(NRDS)combined with ventilator-associated pneumonia(VAP)and put forward corresponding prevention and control measures.Methods The clinical data of 277 children with NRDS combined with VAP from February 2013 to September 2019 were retrospectively reviewed.The clinical data were collected and recorded,and the related factors of death were analyzed by single and multiple factors.Results The mortality rate of children with NRDS combined with VAP was 22.02%;birth gestational age<28 weeks,amniotic fluid pollution,premature rupture of membranes,age at admission<7 h,birth weight<1000 g,APACHE II score>15 points,mechanical ventilation time>7 d,11 types of infection(late type),complications,multi-drug resistant infection,PCT>0.5μg/L were risk factors for death of children with NRDS and VAP(P<0.05);pulmonary surfactants were NRDS with VAP The protective factors of death in children(P<0.05).Multivariate analysis showed that birth weight<1000g,birth gestational age<28 weeks,mechanical ventilation time>7 d,multi-drug resistant infection,procalcitonin(PCT)>0.5μg/L were 5 factors in children with NRDS which were independent risk factors for death(P<0.05).Conclusion The mortality of children with NRDS combined with VAP was high.Strengthening the management of super preterm and extremely low weight infants,doing a lot of prevention and control of multidrug-resistant bacteria infection and early dialing to reduce unnecessary mechanical ventilation time were the main measures to reduce the death of children with NRDS and VAP,and the serum calcitonin monitoring can predict the effect of the treatment of children with NRDS combined with VAP and pre provide basis for clinical work.
作者 谢朝云 熊芸 蒙桂鸾 杨忠玲 陈应强 Xie Zhaoyun;Xiong Yun;Meng Guiluan;Yang Zhongling;Chen Yingqiang(The Third Affiliated Hospital of Guizhou Medical University,Duyun 558000,China)
出处 《湖北民族大学学报(医学版)》 2020年第1期35-38,共4页 Journal of Hubei Minzu University(Medical Edition)
基金 贵州省科技厅联合项目(黔科合LH字[2014]7162号) 贵州省黔南州社会发展科技项目(黔南科合社字[2018]7号)。
关键词 新生儿呼吸窘迫综合征 呼吸机相关性肺炎 死亡 相关因素 LOGISTIC回归分析 neonatal respiratory distress syndrome ventilator-associated pneumonia death related factors logistic regression analysis
  • 相关文献

参考文献7

二级参考文献67

  • 1徐小勇,魏淑珍,张峰,张鹏鹏,施毅.热湿交换器和加热湿化器对呼吸机相关性肺炎的预防价值[J].中国呼吸与危重监护杂志,2011,10(3):241-246. 被引量:11
  • 2郑瑞强,杨从山,邱海波,杨毅,黄英姿.热湿交换细菌过滤器预防呼吸机相关肺炎的临床研究[J].中华结核和呼吸杂志,2005,28(3):203-204. 被引量:18
  • 3谭薇,郭桂芳,王乐强,刘婷,于振刚.早发性与晚发性呼吸机相关性肺炎病原学分析[J].中华医院感染学杂志,2007,17(5):524-526. 被引量:30
  • 4Xu X, Yuan B, Shi Z, et al. Identification of crucial genes in ventilator associated pneumonia through protein - protein interaction network [J]. ExpLungRes, 2015, 41 (6): 316-323. 被引量:1
  • 5Pieracci FM, Rodil M, Haenel J, et al. Screening for Ventilator - Associated Pneumonia in the Surgical Intensive Care Unit: A Single - Institution Analysis of 1, 013 Lower Respiratory Tract Cultures [ J ]. SurgInfect (Larchmt), 2015, 16 (4): 368-374. 被引量:1
  • 6Jones DS, McCoy CP, Andrews GP, et al. Hydrogel Antimicrobial Capture Coatings for Endotracheal Tubes: A Pharmaceutical Strategy Designed to Prevent Ventilator - Associated Pneumonia [ J]. Mol Pharm, 2015, 12 (8): 2928-2936. 被引量:1
  • 7Sweet DG, Camielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants, 2010 update [J]. Neonatology, 2010, 97 (4) : 402 -417. 被引量:1
  • 8Ghaemi S, Mohamadymasodi M, effectes of surfactant replacement distress syndrome [ J]. Zhongguo Kelishadi R. Evaluation of the therapy in neonatal respiratory Dang Dai Er Ke Za Zhi, 2009,11 (3): 188 -190. 被引量:1
  • 9Kuo HT, [,in HC, Tsai CH, et al. A follow - up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants [J]. J Pediatr, 2010, 156 (4) : 537 -541. 被引量:1
  • 10Iwanicki JL, Lu KW, Taeusch HW. Reductions of phospholipase A (2) inhibition of pulmonary surfactant with hyaluronan [ J]. Exp LungRes, 2010, 36 (3): 167-174. 被引量:1

同被引文献55

引证文献8

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部